methylene blue has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Pavlov, PF; Wang, L; Winblad, B | 1 |
| Breydo, L; Glabe, CG; Kayed, R; Milton, S; Necula, M; Tone, P; van der Veer, WE | 1 |
1 review(s) available for methylene blue and Amyloid Deposits
| Article | Year |
|---|---|
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Topics: Alzheimer Disease; Animals; Benzodioxoles; Cholinesterase Inhibitors; Cholinesterases; Curcumin; Humans; Molecular Targeted Therapy; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Quinazolines; Receptors, N-Methyl-D-Aspartate; tau Proteins; Thiadiazoles | 2021 |
1 other study(ies) available for methylene blue and Amyloid Deposits
| Article | Year |
|---|---|
Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.
Topics: Amyloid beta-Peptides; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kinetics; Methylene Blue; Microscopy, Electron, Transmission; Nephelometry and Turbidimetry; Plaque, Amyloid; Protein Binding; Protein Denaturation; Protein Structure, Quaternary; Recombinant Proteins; Solubility | 2007 |